A newly published clinical study suggests that daily vitamin C supplementation may improve outcomes for people with early-stage blood cancers and precancerous blood disorders. Researchers observed fewer adverse events and encouraging survival trends among participants receiving the supplement. Although additional studies are required, scientists describe the findings as a potentially important development in supportive cancer care and preventative medicine.
About the Author
